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AB TRACT 
Puromycin 200 mg/k<T given systemically will block D NA ynt hesi , amino acid in-
corporation and mitosi in t he epidermis of the baby rat . Topically applied olutions 
of 1 ?C puromycin did not have any effect on uptake of H3-tbymidine or on mitosis of 
the epidermal cell . H3-puromycin given intraperitoneally was demon t rated in the 
epidermal cells by radioautographs but no evidence of labebn<T of epidermal cells was 
found by topical application. 
Purom~·cin is knovvn to block protein syn-
thesi after aminoacyl-s RNA is formed (1). 
The chemical structure of t he amino acid-bear-
in<T end of aminoacyl-s RNA and puromycin 
:1re ..., imilar . During the course of protein yn-
thesis, puromycin links to forming polypept ides 
givin <T a terminal peptidyl-puromycin . This 
reaction prevents further addition of peptide 
unit~ and t hus prematurely terminates s~rn the­
.. is of t he protein (2). 
Purom) cin can prevent mitosis and D NA 
"ynthesi~ in vitro in epithelial cells of the lens 
(3) and in leukocytes stimulated with phyto-
hemagglutinin ( 4). 
Baserga et al. (5) reported immediate in-
hibition of protein synthesis and H 3-thymidine 
uptake "·hen 2.5 mgm of puromycin wa given 
intraperitoneally in mice. They detected no 
effect on t hymidine kinase or DNA polymerase. 
Brotherton (6) reported a decrease in protein 
~}-nthesis in pig skin culture treated with 
puromycin. 
Estenson and Baserga (7) injected 2.5 mgm 
puromycin per mou e every hour for 4 hourN 
and injected Ir-t hymidine, H3-leucine and H3-
uridine 30 minutes before sacrifice. Uptake of 
H3-th~·midine and H 3-leucine was decreased 50-
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75% in the first 30 minute~ after the first in-
jection of puromycin. RNA incorporation in-
creased for t he first hour after puromycin, 
then decreased 25-50% in 2-4 hours. 
Powell (8) showed that recovery of DNA 
synthesis under UVL exposure of mou e cells 
in vitro was prevented by puromycin. Twenty 
,ug/ ml of puromycin gave 0-90% inhibition 
of DNA synthesis but thymidine t riphosphate 
levels remained unchanged. DNA polymerase 
activity was undisturbed by puromycin . 
Mueller et al. (9) showed that in vitro 
puromycin will not interfere with DNA syn-
t he i underway at t ime of addition of puromy-
cin to culture. They suggest t hat DNA is in 
two states: (a) a fraction competent for rep-
lication and (b) a fraction requiring protein 
synthesis for init iation . They used 10 ,ug/ml 
puromycm. 
Studzinski (10) showed t hat B ela cells with 
minimal effective concentration of puromycin 
(0.1 f.tg/ ml) suffered some inhibition of mitose 
at 24 hours. There was some accumulation of 
mitotic figures with 0.15 ,ug/ ml for 24 hours. 
At 0.2-1.0 ,ug/ ml there were no mitoses, thus 
indicating preprophase arrest . 
The work that we wi h to report concerns 
investigation of in vivo effects of puromycin 
on epidermal cells of baby rat and psoriatic 
skin . These tudies are concerned with (1) the 
direct uptake of H3-puromycin by epidermal 
cell when applied topically and when injected 
intraperitoneally in baby rat , (2) H3-thymidine 
incorporation into D NA, amino acid incorpo-
ration and t he mitotic index of baby rat skin 
and, (3) the mitotic index in psoriatic kin 
after topical application of puromycin. 
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MATERIALS AND METHODS 
Chemicals and their sources are listed below: 
Puromycin-Nutritional Biochemical Co., Cleve-
land, Ohio. 
H3-puromycin-1800 mc/mM, Amersham/Searle, 
Des Plaines, Ill. 
H 3-thymidine-11.6 CijmM, Amersham/Searle, 
D s Plaines, Ill. 
H 3-leucine-15.0 Ci/mM, chwarz BioResearch, 
rangeburg, N J. 
H 3-hi tidine-5.1 Ci/mM, chwarz BioResearch, 
Orangeburg N J. 
Baby rats used were of the Sprague-Dawley 
strain. The rats were 3-5 days of age when started 
on the xperiments. 
Radioautographs were prepared using the 
method outlined by Epstein et al. (11). 
I. Effect of systemic puromycin on mitosis and 
DNA synthesis. Baby rats were injected with 
puromycin 200 mg/kg or 10 mg/kg intraperito-
neally at 8 a.m. and 9 a.m. One hour before sacri-
fice, 15 f.LC of H3-thymidine was injected intraperi-
ton ally. At given intervals the animals were 
acrificed with ether. Samples of skin were taken 
from the dorsal neck area for fixation in Bouin's 
olution for determining mitoses or in buffered 
formalin for preparing autoradiographs. The num-
b r of milo es and number of cells labeled with 
H3-th:vmidin per 1000 in terfollicular ba al cells 
wer d termined for each animal. Control animals 
wer injected with saline instead of puromycin but 
oth rwi e treated in the arne manner. Twelve ani-
mals w r taken for each study group. 
II. Effect of topical puromycin on mitosit rrnd 
D A synthesis . 1% puromycin was applied to the 
ba k of baby rat in oaked cotton covering an 
ar a 4-5 mm in diam ter and the cotton wa 
cover d with Blend rm® tape wrapped completely 
around tlt Ibidsection of th animal. ·water soak d 
11 ed for controls. The wrapping was 
for 20 hours. Twelv animals from two 
li tt w r u ed. Four of th e animals were not 
included because the mother rat removed the 
Bl nd rm tape. 
H 3-th:vmidine (15 p,c) was injected intraperi-
toneally 19 hour aft r initial application of the 
purom~·cin and the animal ,...-ns sacrificed with ether 
one hour laL r. The mitotic index and lab ling 
ind x w rf' d t rmined bv countino- mito es and 
lab 1 d elL p r 1000 intcrfollicular ba al cell . 
1% pur m~·cin wn appJi d in oaked cotton to a 
5-6 rnm area of p oriatic kin of five p oriatic ub-
j ct . Both th puromycin and aline control wer 
cov r d wi lh Blend rrn { tape for 4 hour . Th 
urom~rcin and aline soaked cotton were replaced 
at th nd of 24 hour . Four mm biop ie w re 
tak n from ach treated area. fix d in Bouin' 
olution and th mitotic ind~x determined by 
ounting th numb r of mito per 1000 inter-
folli ular ba al c I . 
III. Incorpomtion of intraperitoneal and topi-
cally admin . tered H 8-pttrornycin. 108 f.LC H3-puro-
mycin in 0.15 ml wa applied to a 3 cm2 area of the 
back of bab~r rat and allowed to dry. The area 
was then covered by Blenderm® tape and left i? 
place for 7 and 24 hours. The animals were sacn-
ficed with ether and 1 cm2 areas of treated and 
untreated skin were removed and prepared for 
autoradiography. . . 
108 f.LC H3-puromycin in 0.15 m1 was lllJected 
intraperitoneally into baby rats and the animals 
were sacrificed by ether inhalation three hours 
later. Skin from the back of the neck wa fixed and 
prepared for autoradiographs. 
IV. Effect of puromycin on amino acid incor-
poration. 100 mg/ kg puromycin was injected sub-
cutaneously on the ventral surface of young rats 
hourly for 3 hours or half-hourly for 5 hours be-
fore ~ubcutaneous administration of H3-histidine 
or H 3-leucine. Animals were killed with ether an 
hour later. Most of the dorsal skin of each animal 
was removed without including the subcutis. Skin 
specimens were immediately placed in carefully 
flattened aluminum foil envelopes, and the separa-
tion of epidermis from dermis was accompli hed b~· 
placing the aluminum foil envelope with dermis 
down on a lide warmer at 56° C for ~0 econds. 
under a paper pad and staining jar on which lig~t 
manual pressure was maintained. Complete epi-
dermal separation was then easily accomplished 
using clean forceps (histological confirmation of 
clean eparation wa obtained). 
Epidermal specimen (100-150 mg) \H'r then 
obtained from each rat, and approximately 10 mg 
portion (exact weight recorded) were obtained 
for scintillation counting and were treated by one 
of the following methods : 
1. Method A 
,,~a bing con ist d of two 15 minute immersions 
in 5% trichlorac tic acid at room temp rature . 
:;ub 0quent dipping in eli ti ll rd water and dryino- on 
clean filter paper. 
2. Method B 
Duplicate epidermal specimen ''-'€!' €' taken from 
fi,·e babv rats treated with H3-hi tidine and five 
treated .with H3-leucine. These specimen were 
ubjected to tb following equence before olubili-
zation of the epidermi to decrease the pos ibl 
contamination with non-protein radioacti,·ity: 
( 1) Homogenized epidermis in saline. 
(2) Added equal volume of 10% TCA. 
(3) Centrifuged and wa hed precipitate 3 X with 
5% TCA. 
(4) uspended precipitate in 5% TCA and 
heated to 90 C for 15 minutes. 
(5) Extracted precipitate with 50% ethanol. 
100% ethanol, 50% ethanol/50% ether, and 
·with ether. 
Epidermal olubilization was then effected by 
u ing a technique suggested by repre entatives of 
the Beckman Co .. Fullerton. California. Epidermal 
specim n" (10 mg) were digested in 0.5 ml of 2 N 
NaOH in new cintillation counting bottles in an 
incubator at oo C for 30 minutes. Bottle were re-
moved to the bench , cooled to room temperature, 
and 1.5 ml of Beckman Bio-Solve® BBS2 solubilizer 
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1·as added to each bottle from a Cornwall pipett . TABLE I 
' ~entl e shaking produced a clear solution to which 
Jne drop of 0.5 % stannous chloride was added. 
hefore adding 10 ml of Fluoralloy® Beckman 
~cintillation cocktail. Specimens were then counted 
at ambient temperature in a Beckman LS 150 
s intillation counter. The counting efficienc~· for 
tritium in elutions prepared in this manner was 
30 p r cent. 
All tati tical evaluations were based on the 
-imple "t" te-t. 
RE SULTS 
I. Effect of systemic puromycin on mitosis 
and DNA synthesis. T able I shows that the 
mitotic index i definitely depre ned one hour 
after inj ection of puromycin 200 mg/kg (p = 
<0.05). There i almo t complete suppression 
of ::nitoses in two hour (p = <0.01 ) and evi-
dence of partial recovery after 24 hour . The 
10 mg/ k(J' do-age apparently wa without in-
fluence on the mitotic index. 
Table li give evidence of defini te uppre sion 
of D:\A :;:ynthesi , an mea ured by H3-thymidine 
incorporation, in 1.5 hour (p = <0.05) and a 
decrease of clo e t o 90% by 3 hours (p = 
<0.01) \rith t he 200 mg/ kg dosage. There i 
a light SUO'O'e tion of recovery of DNA synthe8is 
b~- 2-t hour with about 0% suppression of 
H3-thymidine uptake. The 20 m(J'/ kg do e level 
was a1 parcntly without effect on H 3-thymidine 
incorporation. 
II. Effect of topical puromycin on mitosis 
and DSA synthesis . 1 o/o puromycin, topically, 
under occlusion, did not uppre either the 
mitotic index or H 3-thymidine uptake. T able 
III hmYs that topical 1 o/o puromycin on p a-
ria tic skin giv ~ no si(J'nificant evidence of sup-
pre;:;sion of mitosis. 
III. Incorporation of intraperitoneal and 
topically arlmini ter cl H3-purornycin. Radio-
auto(J'raphs of bab~· rat kin 7 and 24 hour-
after intraperitoneal }P-puromycin revealed dif-
fu e labeling th rotwh th corium and epidermis. 
orne basal c lls shmred an increased density of 
labeling o,·er the nucleu . 
Howewr topical !P-puromycin did not re-
sult in any detectable labeling of the corium or 
epidermi . 
IY. Effect of puromycin on amino acid 
incorporation. Puromycin 100 ffiO'/ kg each hour 
for 3 hour" or 5 hour~ re~ulted in a sharp drop 
in H3 amino acid uptake by the epidermi 
(p = 0.01 ) . The inhibition varied from 52-75% 
Time Puromycin ~ of post-
animals injection (200 mg/ kg) (10 mg/ kg) 
--
J~ hour 12 4.1 (2- 7) 4.3 (3-7) 
1 hour 12 2.1 (1- 5) 5 . (5- ) 
2 hour 12 0 .3 (0- 1) 7 .1 (4- ) 
3 hour 12 0 .7 (0- 1) 5 .0 (5-9) 
2-1 hour 12 3.1 (1-6) 7 .0 (4- ) 
*Expressed as averarre of all subj c t with the 
extreme in parentheses. 
TABLE II 
H 3 thymidine labeled ba al cell / 1000 
inte1jollicular ba. al cells* 
Puromycin 
Time post- fl of ------- Saline control injection animals 
(200 mg/kg) (20 mg/ kg) 
1;~ hours 45 .2 71.2 CH.5 
(31- 72 ) (53- 7) (50-72) 
3 hours 8 7.4 (j .4 66.0 
(2-12) (54-7 ) (4 - 75 ) 
5 hours 8 7 . 62 .2 5 .1 
(3- 12) (4 - 75 ) (51- 69 ) 
7 hours 14.3 GG . 71.4 




1% puromycin to pi call y lo p. ·o riahc skin. Mi toses 
per 1000 inlerfoll icular basal cells 
Subject Puromycin 1% Saline 
1 15 16 
2 1 13 
3 12 10 
4 14 11 
5 21 19 
- -
Avg. 1G Avg. 15 
of t he control value for leuci11e and hi tidine 
re pectively (see Table IV). 
DI CU ION 
Intraperitoneal admini tration of 200 mg/ kg 
of puromycin induced rapid and evere up-
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TABLE IV 
The effect of puromycin hydrochloride on the incorporation of tritium labeled amino acids 
Mean DPM/mg of epidermal tissue 
Amino acid Exp. Puromycin dose and administration schedule 
Treated group Control group 
H 3-histidine 1 1 mg/ 10 G rat each hour X 3 Method A 1337 Method A 4047 
Method B 1143 Method B 3328 
2 1 mg/ 10 G rat each half-hour X 5 Method A 1640 Method A 4235 
H3_1 uctne 1 1 mg/ 10 G rat eaeh hour X 3 Method A 775 Method A 3022 
Method B 682 Method B 2601 
2 1 mg/ 10 G rat. each half-hour X 5 Method A 1547 Method A 3211 
Met hod A- Lreated gronp , 10 animals/ experiment. 
Method A- rontrol (water-injected) group , 5 animals/ experiment. 
Method B- 5 animals in treated and control groups. 
presion of mitosi ~ and DNA ynthesi in epi-
dermal cell of the baby rat. However, topical 
administration of 1% puromycin gave no indi-
cation of up pre sion of either mito is or DNA 
ynth i . . The fact that topical H 3-puromycin 
did not label epidermal cells but intraperitoneal 
H 3-puromycin did label them, could be ex-
plained by the fact that puromycin did not 
reach the basal cell when applied topically 
but did \Vhen rrjyen intraperitoneally. This may 
be a problem of penetration of the horny layer 
by puromycin or possibly metabolism of 
puromycin before it reache the basal cell . 
1 ven in psoriatic skin, where pre umably the 
barrier to penetration is damaged, topical 
puromycin did not depres the mitotic index. 
. .\. recent re,·iew by Ba erga discus es the 
biochemistry of the cell cycle (12). It is not 
knovn1 preci, cly how puromycin interferes with 
DN. ynthe i and mito is but it i probably 
due to it. inhibition of protein S:J nthe is. 
Littlefield ( 13) hu found that puromycin pre-
Y nt the reappearance of hymidine kinase 
nc ivity during the ~phase growth of mou e 
fibrobla t in ulture. I·Gsbimoto and Lieberman 
(14) demon trated a puromycin sensitive step 
in th 0 2 pha e of ms,mmalian cell in culture 
nnd Tobe et al. (15) reported on puromycin 
blockina a tacr later in G2 in Chine e hamster 
c l1 . In our tudy th euppre sion of the mitotic 
ind x 30 minu after puromycin uggest a 
blo k in th G~ pha~e. A previou repor by 
Robin«on an cl tough ton ( 16) shows e,·idence 
for a very early suppression of mitosi by 
methotrexate. E ten en and Baserga (10) re-
ported that crypt cells of the mouse inte tine 
are inhibited in D A synthesis by puromycin. 
They found DNA ynthesis (S-phase) to be 
more sensitive to puromycin than G2 or mitosis. 
They concluded that DNA synthesis "eemed 
to be completely dependent on protein svn-
the i . 
Baseraa reported no change in thymidine 
kina e or D~ A polymera e levels in mouse 
cells treated with 2.5 mgm per hour per animal 
(5). Although Estensen et al. (7) reported 
necro i::1 of actiYely diYiding cells (small intes-
tine, germinal center of spleen and lymphoid 
ti~ ue) trented "·ith puromycin, ''"e did not 
ob erve necrosi of rat epidermal cells with 
pnrom~·cin. These ame authors (7) also re-
ported a sharp decrease in amino ac id uptake 
in the presence of puromycin . 
The effect of puromycin on epidermal cell 
function is dramatic and rapid when the drug 
i giYen y~temically. It is curious that there 
is no effect by topical application. Thi model 
. tem hould be u eful in the inve tigation of 
other an tim eta bolite for topical and systemic 
effect on pidermal cell proliferation. 
AJthouah l\Iethod B, which more critically 
excludes non-protein radioacti' ity than i\Iethod 
. , decrea ~ed the incorporated count ~ , the 
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lmromycm effect of lowering amino acid in-
corporation was still quite evident. 
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